LONDON, Aug 10 (Reuters Breakingviews) - The ingredients in ingredients are becoming pricier. On Tuesday, Dutch flavourings and preservatives maker Corbion’s (CORB.AS) shares fell as much as 9% after higher prices for freight and raw materials forced it to downgrade its 2021 EBITDA margin target from over 15% this year so far to as little as 13%. The slump may have a read-across for British rival Tate & Lyle (TATE.L), which last month sold a controlling stake in its sweeteners business to private equity, leaving it, like Corbion, as a pure-play seller of ingredients that make food tastier and longer-lasting. Corbion’s shares have more than tripled since it pulled off a similar split in 2012. The Dutch group’s stock was arguably a little rich. Before Tuesday’s decline, the group had been trading at a toppy 30 times 2022 earnings. The multiple has now fallen to 27 times. Tate & Lyle, however, still looks cheap, valued at just 13 times forward earnings. Its shareholders still have plenty to gain from the separation, but Chief Executive Nick Hampton may have to work a little harder. (By Dasha Afanasieva) On Twitter http://twitter.com/breakingviews Capital Calls - More concise insights on global finance: Amazon rolls well enough with the punches in India read more Ex-SPAC combo doubles Golden Nugget money read more Brookfield digs for returns in Texas read more Macquarie goes fishing in UK water dregs read more Delivery Hero diversifies its portfolio of rivals read more